IBD
Signal score, how each part rates
ActionabilityPrevalenceStakesEvidence strengthNovelty
See the full rubric →Clinical features and outcomes of perianal disease in pediatric-onset Crohn's disease: A comparative analysis according to age at diagnosis.
Clinical takeawayConsider genetic testing for monogenic mutations, particularly IL-10RA, in VEO-IBD patients with perianal disease. Thalidomide and/or HSCT may be individualized options for selected monogenic VEO-IBD patients, but avoid generalizing thalidomide to all VEO-IBD.
What it foundVEO-IBD with PD had a monogenic mutation rate of 77.27% (17/22), predominantly IL-10RA, and lower clinical remission (71.93% vs 95.40% in non-PD).
ContextConfirms that VEO-IBD with PD is associated with monogenic mutations and poorer outcomes, refining prior evidence on disease severity and treatment response in pediatric CD. Highlights the need for cautious use of thalidomide in this population.
No standard claimed for this paper
Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.
Mi M … Zhong X · BMC Gastroenterology · IF 2.5 · PubMed ↗